C₂N Diagnostics reports positive data for new Alzheimer’s blood test
The combination of the p-tau217 ratio and Aβ42/40 ratio enables the identification of Alzheimer’s brain pathology patients.
Neurology Devices
Latest in
Neurology Devices
ArchiMed acquires neurodiagnostic devices provider Natus Medical
Natus shareholders received $33.50 in cash for each share of company common stock.
The future of ALS devices: next gen assistive technology aims to give patients a voice
Brain-computer interfaces, IoT and AI to fuel the advancement of assistive technology devices for ALS patients.
By
DyAnsys receives US FDA approval for First Relief neurostimulation device
First Relief is placed behind the ear and provides continuous pulses of low-level electrical current.
C2N introduces new test to aid Alzheimer’s diagnosis
p-tau MAA is expected to provide researchers with an additional tool for Alzheimer’s and brain health studies.
Study says Diadem blood test accurately predicts Alzheimer’s disease
The AlzoSure Predict test has already received Breakthrough Device designation from the US FDA.
Rehabtronics announces availability of ReGrasp Bionic Glove in US
The FDA-cleared ReGrasp Bionic Glove can be used to improve hand function after stroke or injury.
ProSomnus signs business combination agreement with Lakeshore
The companies expect to receive a minimum additional $10m in equity from Lakeshore's trust account or a PIPE.